Jimena Del Risco-Zevallos

Jimena Del Risco-Zevallos

Auto-generated profile, based on publicly available information

Jimena Del Risco-Zevallos

Department of Nephrology, Hospital Clinic Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Blood Purification
Verified
Journal Article
Open access
PDF file
Francisco MaduellFrancisco Maduell
Francisco Maduell
JBJose Jesus Broseta
Jose Jesus Broseta
DRDiana Rodríguez-Espinosa
Diana Rodríguez-Espinosa
JRJimena Del Risco-Zevallos
Jimena Del Risco-Zevallos
MGMiquel Gomez
Miquel Gomez
NRNaira Rico
Naira Rico
Introduction: The medium cut-off Elisio HX dialyzer by Nipro became commercially available in Europe in 2021, but there are still no reports of in vivo data. This study aimed to evaluate the safety and efficacy of it compared with previously evaluated hemodialysis (HD), expanded HD (HDx), and postdilution hemodiafiltration (HDF) treatments. Methods: A prospective study was carried out on 18 patients who underwent 5 dialysis sessions: FX80 Cordiax in HD, Elisio H19 in HD, Elisio HX19 in HDx, Theranova 400 in HDx, and FX80 Cordiax in HDF. The reduction ratios of urea, creatinine, ß2-microglobulin, myoglobin, kappa FLC, prolactin, α1-microglobulin, α1-acid glycoprotein, lambda FLC, and albumin were compared. Dialysate albumin loss was measured. Results: The comparison between the different dialysis modalities revealed no difference for small molecules, but HDx and HDF were significantly more efficient than HD for medium and large molecule removal. The efficacy of Elisio HX19 dialyzer in HDx was similar to the Theranova 400, superior to both dialyzers in HD, and slightly lower than HDF. Albumin losses in dialysate with HD dialyzers were less than 1 g, but between 1.5 and 2.5 g in HDx and HDF. The global removal score (GRS) values with HDx treatments were statistically significantly higher than those with HD. The highest GRS was obtained with the helixone dialyzer in HDF. Conclusions: The new MCO dialyzer, Elisio HX, performs with excellent behavior and tolerance. It represents an upgrade compared to their predecessor and is very close to the removal capacity of HDF treatment.

21 January 2022 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Closed access
JRJimena Del Risco-Zevallos
Jimena Del Risco-Zevallos
JPJuan Piñeyroa
Juan Piñeyroa
DRDiana Rodríguez-Espinosa
Diana Rodríguez-Espinosa
MGMarta Garrote
Marta Garrote
AGAnna Gaya
Anna Gaya
MRManel Vera Rivera
Manel Vera Rivera
Here, we report a case of a patient with cloudy effluent that was initially diagnosed as bacterial peritonitis. The persistence of a cloudy effluent despite antibiotic therapy led to an extensive peritoneal dialysis (PD) effluent analysis, with the final diagnosis being high-grade B-cell lymphoma. This case will increase the awareness of this rare presentation of a lymphoproliferative disorder reminding clinicians to consider this diagnosis as a part of the differential diagnosis PD effluent.